Welcome to LookChem.com Sign In|Join Free

CAS

  • or

223788-14-5

4-Pyrimidinecarboxylicacid,1,6-dihydro-6-oxo-,ethylester(9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

223788-14-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 223788-14-5 Structure

  • Basic information

    1. Product Name: 4-Pyrimidinecarboxylicacid,1,6-dihydro-6-oxo-,ethylester(9CI)
    2. Synonyms: 4-Pyrimidinecarboxylicacid,1,6-dihydro-6-oxo-,ethylester(9CI);4-PYRIMIDINECARBOXYLIC ACID, 1,6-DIHYDRO-6-OXO-, ETHYL ESTER;ethyl 6-hydroxypyrimidine-4-carboxylate;ethyl 6-oxo-1,6-dihydropyriMidine-4-carboxylate;ethyl 1,6-dihydro-6-oxopyriMidine-4-carboxylate;1,6-Dihydro-6-oxo-4-pyriMidinecarboxylic acid ethyl ester;Ethyl 6-oxo-3,6-dihydropyriMidine-4-carboxylate;1,6-Dihydro-6-oxo-pyrimidin-4-carboxylic acid ethyl ester
    3. CAS NO:223788-14-5
    4. Molecular Formula: C7H8N2O3
    5. Molecular Weight: 168.15
    6. EINECS: N/A
    7. Product Categories: GLYCINESCAFFOLD;Building Blocks;Pyrimidine
    8. Mol File: 223788-14-5.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 276.7±50.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.33g/cm3
    6. Refractive Index: 1.567
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. PKA: 6.99±0.40(Predicted)
    10. CAS DataBase Reference: 4-Pyrimidinecarboxylicacid,1,6-dihydro-6-oxo-,ethylester(9CI)(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-Pyrimidinecarboxylicacid,1,6-dihydro-6-oxo-,ethylester(9CI)(223788-14-5)
    12. EPA Substance Registry System: 4-Pyrimidinecarboxylicacid,1,6-dihydro-6-oxo-,ethylester(9CI)(223788-14-5)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 223788-14-5(Hazardous Substances Data)

223788-14-5 Usage

Chemical Properties

Tan powder

Check Digit Verification of cas no

The CAS Registry Mumber 223788-14-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,3,7,8 and 8 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 223788-14:
(8*2)+(7*2)+(6*3)+(5*7)+(4*8)+(3*8)+(2*1)+(1*4)=145
145 % 10 = 5
So 223788-14-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H8N2O3/c1-2-12-7(11)5-3-6(10)9-4-8-5/h3-4H,2H2,1H3,(H,8,9,10)

223788-14-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 4-oxo-1H-pyrimidine-6-carboxylate

1.2 Other means of identification

Product number -
Other names 1,6-DIHYDRO-6-OXO-4-PYRIMIDINECARBOXYLIC ACID ETHYL ESTER

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:223788-14-5 SDS

223788-14-5Relevant articles and documents

(3-phenylisoxazolidin-2-yl)(piperidin-4-yl)methanone derivatives and pharmaceutical composition for use in preventing or treating kinase-related disease

-

Paragraph 0245-0249, (2020/10/19)

The present invention relates to a (3-phenylisoxazolidin-2-yl)(piperidin-4-yl)methanone derivative represented by the following chemical formula 1, and a pharmaceutical composition for treating kinase-related diseases including the same as an active ingredient. The (3-phenylisoxazolidin-2-yl)(piperidin-4-yl)methanone derivative according to one aspect shows an excellent activity of inhibiting at least one kinase selected from the group consisting of ABL1, ABL2, BRAF, CDK11, CDK8, CDKL2, CIT, CSF1R, DDR1, DDR2, FLT3, KIT, LOK, LTK, MUSK, PAK3, PDGFRA, PDGFRB, RAF1 and RIPK1, and thus can be used for treating kinase-related diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 223788-14-5